North London Council announces part a partnership with telecoms infrastructure operator to deploy small cell technology ...

Alix E. Harrow's new book follows a weary historian pulled into a magical time loop with the legendary knight he’s adored ...

NASHVILLE, Tenn., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its ...

Infrastructure company Cellnex has partnered with Harrow Council as part of an agreement to bolster mobile connectivity ...

Boll stated, "we are updating our full year revenue outlook to a range of $270 million to $280 million." He noted, "While our original target is still within reach, this new range is one I believe we ...

Harrow’s accelerating revenue and expanding product portfolio may help explain why a fundamentals-focused investment firm just made it a new position.

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that man ...

Discover why Harrow Inc. (HROW) is a strong buy in 2024—explosive growth from Vevye, rising margins, and a $175 price target.

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Applications (NDAs) ...

More than a dozen people died while in drug treatment in Harrow over the last few years, new figures show. It comes as the ...